Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing Invitae makes it affordable and accessible to everyone who can benefit. The dedication to the mission is fueling explosive growth, with both the test volume and revenue doubling year-over-year for the past four years. Invitae's team has grown from 300 employees to more than 1,000 in just two years and they have helped hundreds of thousands of patients get the answers they need. Why medical genetics? Within each of them lies information coded in their DNA that can transform their health. Unlocking those answers to make medicine more personalized requires highly specialized, multidisciplinary collaboration. The company's platform is setting the standard for the exploding medical genetics industry by harnessing the power of advanced technologies – robotics, artificial intelligence, machine learning, software engineering – and world-class genetic expertise. Invitae provides genetic information that guides decisions for patients facing a vast array of health questions, from ultra-rare diseases and the most common cancers to starting a family. The team driving the mission thrives in a culture designed to enable innovation at scale. The team is grounded in freedom with responsibility and a universal sense of urgency and ownership. Employees are empowered to speak up, try new things, and make decisions that push them forward. The company provides all employees with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles, and the satisfaction of doing meaningful work.
83 Reviews
work life balance is incredible. I get paid to babysit systems that pretty much take care of themselves.
bankruptcy and lack of any motivation or enthusiasm as everyone waits for the inevitable
Universal germline genetic testing benefited patients with breast cancer and their physicians in implementing effective precision treatments and personalized disease management, according to study results published in JAMA Network Open.“This research stemmed from the question of how effective…
Jones Day advised The Riverside Company on the deal. InVita Healthcare Technologies, a leading software solutions provider to healthcare, blood centers, public health, and public safety …